Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

Back to all news

Webinar of Interest to Members - “The ‘End’ of the COVID-19 Emergency: The Ryan Haight Act, Telemedicine, and Next Steps?” on Thursday, March 23, 2023 at 12 Noon EST

Posted 3/13/2023

The COVID-19 pandemic emergency forced federal regulators to take extraordinary measures to ensure that patients were permitted continued access to important medicines. These government measures included granting temporary exemptions from certain FDA and DEA legal requirements. When the public health emergency ends on May 11, 2023, so do these exemptions. By almost all accounts, these exemptions also improved prescribing and dispensing of medication to patients that need them. The ?end? of the pandemic emergency leaves many in the regulated industry wondering how this will affect certain prescribing and dispensing practices that have become ubiquitous since the pandemic?s inception.

Hyman, Phelps & McNamara, P.C.?s panel of legal experts (Karla Palmer, John Claud, Jeff Wasserstein, John Gilbert and Kalie Richardson) invite you to spend your lunch hour (or hour-and-a-half?) with us as we address implications related to the looming end of the pandemic declaration. We will discuss the state of relevant laws prior to our new ?COVID reality? and telemedicine issues during and post-pandemic, both with respect to the prescribing of controlled substances and non-controlled drugs. Last, but certainly not least, we look forward to introducing our newest colleague, John WM Claud, who recently joined HPM from the Department of Justice?s Consumer Protection Branch. John will present on considerations and his learned perspective for the future of teleprescribing.

Please see detailed information in the attached flyer, including a link to register for our free webinar. We hope you join us!

Back to all news

Sponsor Spotlight

IQVIA Compliance Solutions

Operational and regulatory resources for navigating the regulatory landscape with confidence

The IQVIA Difference

IQVIA has been an industry expert in DEA and state operational compliance and a leading provider of regulatory services since 1991. Our long-standing compliance solutions support the industry and the health care community in the areas of the Controlled Substance Act, Prescription Drug Marketing Act and more specifically, state pharmacy and wholesale distribution regulatory issues, as well as operational best practices.

Staffed by former DEA investigators, policy makers and industry experts, IQVIA offers comprehensive solutions to support Registrants at any stage of the journey to achieve regulatory compliance. Our expert services also include:

  • Unparalleled experience developing SOM solutions
  • State services for licensing assistance and other requirements
  • Proactively monitor the regulatory and enforcement landscapes
  • Bridge the gap between regulation and practice

All Sponsors